Comparison of the incidence of sexually transmitted infections and vaginal microbiota disturbances associated with opportunistic microorganisms in women in 2019–2021


DOI: https://dx.doi.org/10.18565/epidem.2023.13.1.87-93

Makhova T.I., Goloveshkina E.N., Akimkin V.G.

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia
Objective. To compare DNA detection cases in sexually transmitted infections (STIs) and vaginal microbiota disturbances (VMDs) associated with opportunistic microorganisms in 2019–2021 and to assess their association.
Subjects and methods. The results of the 2019-021 laboratory studies for DNA of STI pathogens and microorganisms associated with bacterial vaginosis, aerobic vaginitis, and vulvovaginal candidiasis were analyzed in 128,512 women.
Results. During the study period, there was an increase in cases of N. gonorrhoeae DNA detection, while no significant differences were found for T. vaginalis and M. genitalium. For C. trachomatis, there was a decline in the number of detected cases in 2020 and a return to the figure of 2019 in 2021. Significantly fewer cases of VMDs were detected in 2020, whereas the number of cases increased in 2021 versus 2019. There was an increase in the chance of infection for a number of STIs in the presence of VMDs.
Conclusion. The 2020 pandemic period did not substantially affect the decline in the number of detected STIs. The increased chance of infection for a number of STIs in VMDs should be taken into account when choosing the scope of laboratory tests and prescribing therapy. Further work is needed to introduce effective STI prevention measures.

Literature


1. WHO. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. https://www.who.int/publications/ i/item/9789240027077


2. Schnitzler L., Jackson L.J., Paulus A.T.G., Roberts T.E., Evers S.M.A.A. Intersectoral costs of sexually transmitted infections (STIs) and HIV: a systematic review of cost-of-illness (COI) studies. BMC Health Serv. Res. 2021; 21(1): 1179. DOI: 10.1186/s12913-021-07147-z


3. Доброхотова Ю.Э., Бондаренко К.Р., Шадрова П.А. Современный взгляд на инфекционный фактор и возможные патогенетические механизмы ранних репродуктивных потерь. Проблемы репродукции. 2020; 26(3): 23–30. DOI: 10.17116/repro20202603123


Dobrokhotova Yu.E., Bondarenko K.R., Shadrova P.A. [Current view on infectious factor of early reproductive losses and possible pathogenetic mechanisms]. Russian Journal of Human Reproduction 2020; 26(3): 23–30. (In Russ.). DOI: 10.17116/repro20202603123


4. Савичева А.М., Тапильская Н.И., Шипицына Е.В., Воробьева Н.Е. Бактериальный вагиноз и аэробный вагинит как основные нарушения баланса вагинальной микрофлоры особенности диагностики и терапии. Акуш. и гин. 2017; (5): 24–31. DOI: 10.18565/aig.2017.5.24-31


Savicheva A.M., Tapilskaya N.I., Shipitsyna E.V., Vorobyeva N.E. [Bacterial vaginosis and aerobic vaginitis as major vaginal microflora balance disorders: Diagnostic and therapeutic characteristics]. Obstetrics and Gynecology 2017; (5): 24–31. (In Russ.). DOI: 10.18565/aig.2017.5.24-31


5. Ковалык В.П., Матушевская Е.В., Владимирова Е.В. Вагинальные выделения у женщин без риска инфекций, передаваемых половых путем. Акуш. и гин. 2018; (12): 171–6. DOI: 10.18565/aig.2018.12.171-176


Kovalyk V.P., Matushevskaya E.V., Vladimirova E.V. [Vaginal discharge unassociated with sexually transmitted infections in reproductive-aged women]. Obstetrics and Gynecology 2018; (12): 171–6. (In Russ.). DOI: 10.18565/aig.2018.12.171-176


6. Потекаев Н.Н., Купеева И.А., Иванова М.А., Фриго Н.В., Доля О.В., Жукова О.В. и др. Заболеваемость инфекциями, передаваемыми половым путем, в Российской Федерации в 2014–2019 гг. Клиническая дерматология и венерология 2021; 20(1): 25–32. DOI: 10.17116/ klinderma20212001125


Potekaev N.N., Kupeeva I.A., Ivanova M.A., Frigo N.V., Dolya O.V., Zhukova O.V. et al. [Incidence of sexually transmitted infections in the Russian Federation in 2014–2019]. Russian Journal of Clinical Dermatology and Venereology 2021; 20(1): 25–32. (In Russ.). DOI: 10.17116/klinderma 20212001125


7. Eastment M.C., McClelland R.S. Vaginal microbiota and susceptibility to HIV. AIDS 2018; 32(6): 687–98. DOI: 10.1097/QAD.0000000000001768


8. Hiam C., Helen A.W., Alex S., Elzahraa M., Laith J.A.R. Epidemiology of Treponema pallidum, Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and herpes simplex virus type 2 among female sex workers in the Middle East and North Africa: systematic review and meta-analytics. J. Glob. Health 2019; 9(2): 020408. DOI: 10.7189/jogh.09.020408


9. Tamarelle J., Thiébaut A., de Barbeyrac B., Bébéar C., Ravel J., Delarocque-Astagneau E. The vaginal microbiota and its association with human papillomavirus, Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium infections: a systematic review and meta-analysis. Clin. Microbiol. Infect. 2019; 25(1): 35–47. DOI: 10.1016/j.cmi.2018.04.019


10. Sherrard J., Wilson J., Donders G., Mendling W., Jensen J. 2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. Int. J. STD AIDS 2018; 29(13): 1258–72. DOI: 10.1177/0956462418785451


11. Rumyantseva T.A., Bellen G., Savochkina Y.A., Guschin A.E., Donders G. Diagnosis of aerobic vaginitis by quantitative real-time PCR. Arch. Gynecol. Obstet. 2016; 294(1): 109–14. DOI: 10.1007/s00404-015-4007-4


12. Unemo M., Ross J., Serwin A. B., Gomberg M., Cusini M., Jensen J.S. 2020 European guideline for the diagnosis and treatment of gonorrhoea in adults. Int. J. STD AIDS 2020; 0(0): 1–17. DOI: 10.1177/0956462420949126


13. Jensen J., Cusini M., Gomberg M., Moi H. 2016 European guideline on Mycoplasma genitalium infections. Eur. Acad. Dermatol. Venereol. 2016; 30(10): 1650–6. DOI: 10.1111/jdv.13849


14. Lanjouw E., Ouburg S., de Vries J. H., Stary A., Radcliffe K., Unemo M. 2015 European guideline on the management of Chlamydia trachomatis infections Int. J. STD AIDS 2016; 27(5): 333–48. DOI: 10.1177/0956462415618837


15. Workowski K.A., Bolan G.A. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2021. MMWR Recomm. Rep. 2021; 70(4): 1–187. DOI: 10.15585/mmwr.rr7004a1


16. Клинические рекомендации. Хламидийная инфекция. М.: Общероссийская общественная организация «Российское общество дерматовенерологов и косметологов», Российское общество акушеров-гинекологов. 2021. 35 с.


[Clinical guidelines. Chlamydia trachomatis infections]. Moscow: All-Russian public organization «Russian Society of Dermatovenerologists and Cosmetologists», Russian Society of Obstetricians and Gynecologists. 2021. 35 p. (In Russ.).


17. Клинические рекомендации. Гонококковая инфекция. М.: Общероссийская общественная организация «Российское общество дерматовенерологов и косметологов», Российское общество акушеров-гинекологов. 2021. 38 с.


[Clinical guidelines. Gonorrhoea]. Moscow: All-Russian public organization «Russian Society of Dermatovenerologists and Cosmetologists», Russian Society of Obstetricians and Gynecologists. 2021. 38 p. (In Russ.).


18. Клинические рекомендации. Урогенитальный трихомониаз. М.: Общероссийская общественная организация «Российское общество дерматовенерологов и косметологов», Российское общество акушеров-гинекологов. 2021. 35 с.


[Clinical guidelines. Trichomoniasis]. Moscow: All-Russian public organization «Russian Society of Dermatovenerologists and Cosmetologists», Russian Society of Obstetricians and Gynecologists. 2021. 35 p. (In Russ.).


19. Клинические рекомендации. Урогенитальные заболевания, вызванные M. genitalium. М.: Общероссийская общественная организация «Российское общество дерматовенерологов и косметологов», Российское общество акушеров-гинекологов. 2021. 34 с.


[Clinical guidelines. M. genitalium infection]. Moscow: All-Russian public organization «Russian Society of Dermatovenerologists and Cosmetologists», Russian Society of Obstetricians and Gynecologists. 2021. 34 p. (In Russ.).


20. Клинические рекомендации по диагностике и лечению заболеваний, сопровождающихся патологическими выделениями из половых путей женщин. М.: Российское общество акушеров-гинекологов, 2019. 56 с.


[Clinical guidelines on the management of vaginal discharge]. Moscow: Russian Society of Obstetricians and Gynecologists, 2019. 56 p. (In Russ.).


21. Клинические рекомендации. Бактериальный вагиноз. М.: Общероссийская общественная организация «Российское общество дерматовенерологов и косметологов». 2022. 26 с.


[Clinical guidelines. Bacterial vaginosis]. Moscow: All-Russian public organization «Russian Society of Dermatovenerologists and Cosmetologists». 2022. 26 p. (In Russ.).


22. Клинические рекомендации. Урогенитальный кандидоз. М.: Общероссийская общественная организация «Российское общество дерматовенерологов и косметологов». 2020. 26 с.


[Clinical guidelines. Candidosis]. Moscow: All-Russian public organization «Russian Society of Dermatovenerologists and Cosmetologists». 2020. 26 p. (In Russ.).


23. Explore CDC’s Atlas Plus. HIV, Hepatitis, STD, TB, Social Determinants of Health Data. https://gis.cdc.gov/grasp/nchhstpatlas/tables.html


24. Lukas B., Manuel C., Dianne E.G., Myrofora G., Florian S. H., Gian-Reto L. et al. Prevalence of Mycoplasma genitalium in different population groups: systematic review and meta-analysis. Sex Transm. Infect. 2018; 94(4): 255–62. DOI: 10.1136/sextrans-2017-053384


25. Махова Т.И., Румянцева Т.А., Гущин А.Е., Акимкин В.Г. Ассоциация инфекций, передаваемых половым путем, и различных нарушений вагинальной микробиоты среди женщин репродуктивного возраста. Клиническая дерматология и венерология 2020; 19(2): 181–6. DOI: 10.17116/klinderma202019021181


Makhova T.I., Rumyantseva T.A., Gushсhin A.E., Akimkin V.G. [Association of sexually transmitted infections and various disorders of the vaginal microbiota among women of reproductive age]. Russian Journal of Clinical Dermatology and Venereology 2020; 19(2): 181–6. (In Russ.). DOI: 10.17116/klinderma202019021181


26. Rodríguez-Cerdeira C., Gregorio M.C., Molares-Vila A., López-Barcenas A., Fabbrocini G., Bardhi B. et al. Biofilms and vulvovaginal candidiasis. Colloids Surf B Biointerfaces. 2019; 174: 110–25. DOI: 10.1016/j.colsurfb.2018.11.011


27. Donders G.G.G. Definition and classification of abnormal vaginal flora. Best. Pract. Res. Clin. Obstet. Gynaecol. 2007; 21(3): 355–73. DOI: 10.1016/j.bpobgyn.2007.01.002


About the Autors


Tamara I. Makhova, Researcher, Laboratory for Molecular Diagnosis and Epidemiology of Reproductive Organ Infections, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; tamara.dolgova89@gmail.com; https://orcid.org/0000-0001-7502-6473
Elena N. Goloveshkina, Cand. Biol. Sci., Head, Laboratory for Molecular Diagnosis and Epidemiology of Reproductive Organ Infections, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; goloveshkina@cmd.su; https://orcid.org/0000-0002-0536-2874
Professor Vasily G. Akimkin, Academician of the Russian Academy of Sciences, MD, Director, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; crie@pcr.ru; https://orcid.org/0000-0003-4228-9044


Similar Articles


Бионика Медиа